180 related articles for article (PubMed ID: 37839264)
1. Bioanalytical strategies to evaluate cisplatin nanodelivery systems: From synthesis to incorporation in individual cells and biological response.
Gutierrez-Romero L; Díez P; Montes-Bayón M
J Pharm Biomed Anal; 2024 Jan; 237():115760. PubMed ID: 37839264
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systems.
Chang R; Chen L; Qamar M; Wen Y; Li L; Zhang J; Li X; Assadpour E; Esatbeyoglu T; Kharazmi MS; Li Y; Jafari SM
Adv Colloid Interface Sci; 2023 Aug; 318():102933. PubMed ID: 37301064
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.
Farinha P; Pinho JO; Matias M; Gaspar MM
Drug Deliv Transl Res; 2022 Jan; 12(1):49-66. PubMed ID: 33616870
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
6. Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy.
Toro-Cordova A; Flores-Cruz M; Santoyo-Salazar J; Carrillo-Nava E; Jurado R; Figueroa-Rodriguez PA; Lopez-Sanchez P; Medina LA; Garcia-Lopez P
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200551
[TBL] [Abstract][Full Text] [Related]
7. Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.
Groessl M; Hartinger CG
Anal Bioanal Chem; 2013 Feb; 405(6):1791-808. PubMed ID: 23070042
[TBL] [Abstract][Full Text] [Related]
8. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
Zhang S; Sun J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
10. The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.
Zabielska-Koczywąs K; Lechowski R
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215573
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Targeting Peptide-based Nanodelivery for Cancer Treatment.
Ehsan S; Covarrubias-Zambrano O; Bossmann SH
Curr Protein Pept Sci; 2022; 23(10):657-671. PubMed ID: 35619295
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in nanotechnology-based drug carriers for resveratrol delivery.
Li C; Wang Z; Lei H; Zhang D
Drug Deliv; 2023 Dec; 30(1):2174206. PubMed ID: 36852655
[TBL] [Abstract][Full Text] [Related]
13. Strategies for improving drug delivery: nanocarriers and microenvironmental priming.
Khalid A; Persano S; Shen H; Zhao Y; Blanco E; Ferrari M; Wolfram J
Expert Opin Drug Deliv; 2017 Jul; 14(7):865-877. PubMed ID: 27690153
[TBL] [Abstract][Full Text] [Related]
14. [Comparison on antitumor activity of cisplatin-loaded liposomes and nanoparticles in vitro].
Sun XY; Liang WQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 40(4):408-13. PubMed ID: 21845755
[TBL] [Abstract][Full Text] [Related]
15. Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance.
Yang X; Yu Y; Huang X; Chen Q; Wu H; Wang R; Qi R; Miao Y; Qiu Y
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():96-104. PubMed ID: 30606608
[TBL] [Abstract][Full Text] [Related]
16. Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research.
Argenziano M; Arpicco S; Brusa P; Cavalli R; Chirio D; Dosio F; Gallarate M; Peira E; Stella B; Ugazio E
Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683830
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
18. Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020).
Fotopoulou E; Titilas I; Ronconi L
Recent Pat Anticancer Drug Discov; 2022; 17(1):42-54. PubMed ID: 34493191
[TBL] [Abstract][Full Text] [Related]
19. Toxicological profile of therapeutic nanodelivery systems.
Bimbo LM; Peltonen L; Hirvonen J; Santos HA
Curr Drug Metab; 2012 Oct; 13(8):1068-86. PubMed ID: 22380014
[TBL] [Abstract][Full Text] [Related]
20. Nano-drug delivery system: a promising approach against breast cancer.
Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
